Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vemircopan Monotherapy in PNH
NCT04170023Phase 2Terminated
- Sponsor
- Alexion Pharmaceuticals
- Start
- Dec 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of vemircopan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Alexion Pharmaceuticals. Started Dec 2019; status: terminated.
02
Drugs
vemircopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT04170023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04170023.